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Preface 
 
The decision to have the Deep Brain Stimulation (DBS) procedure is often a daunting one for many of 
those with Parkinson’s disease (PD) and who have the option of receiving this treatment. It can also 
be daunting for carers. Many find the decision to have elective brain surgery a difficult one, a 
decision often made with limited knowledge or understanding of possible outcomes.  
Parkinson’s disease is a complex neurological disorder with a wide range of motor and non-motor 
symptoms. Those living with the disease often seem to have an almost unique combination of its 
symptoms. People contemplating DBS are naturally curious about the outcomes they may 
experience. Their carers, family and friends share in this curiosity.  
It is widely recognised that successful outcomes from DBS for PD depend in part on those involved 
having realistic expectations of the outcomes. Those involved include the person with PD, their 
carer, family and friends. Information about DBS is available from the clinical team responsible for 
the procedure. More is available from published medical literature, but this isn’t always in a form 
that the general public have access to, or are able to fully understand.  
Those that have already had DBS for PD are another valuable source of information. The challenge 
with this source is to ensure that the information gained in this way is representative. The feedback 
we receive from our support group network, in particular from the Deep Brain Stimulation Support 
Group of Parkinson’s Queensland, suggested that the response to DBS is highly variable between 
individuals and can also vary over time. Further, perceptions of outcomes from the DBS procedure 
can sometimes be different for DBS recipients and carers. Recognition of this possible range of 
outcomes was the catalyst for the survey described here, the goal being to provide broadly based 
information about outcomes collected in a systematic way for a representative number of cases. 
The results from this study are intended to better inform those contemplating the procedure about 
the range of outcomes and how these outcomes can change over time, based on experiences 
reported by those who have had DBS. It is also directed to those who have had the procedure and 
are interested to learn how their experiences compare with others. Carers, families and friends may 
also find useful information from this survey better equipping them to support DBS recipients during 
the post-DBS journey. It may also help service planners and providers identify areas of need guiding 
the development of more targeted services. As such it complements the efforts of organisations 
such as the Cochrane Collaboration (http://www.cochrane.org/) devoted to providing accessible 
systematic reviews of treatment outcomes to provide additional guidance for health decisions. 
Revision 1 
Further analysis has been conducted on the information collected in this survey, guided by feedback 
from readers. As a result, this revision includes more information about the DBS experience profile 
of participants and some disaggregation of scores from DBS recipients and carers showing more 
clearly any differences in assessments of DBS outcomes from these two groups. As a consequence 
the discussion has been largely rewritten and restructured to improve clarity. Some minor errors 
have also been corrected. The authors would like to thank readers for their helpful comments. 
NWP 
August 2015 
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GLOSSARY 
Bradykinesia Slowness of movement 
C Carers 
DBS Deep brain stimulation 
DDS Dopamine dysregulation syndrome, characterised by self-control problems  
DRT Dopamine replacement therapy 
Dyskinesia Random jerky movements, a side effect of high levels of levodopa intake 
GPi Globus pallidus internus 
ICD Impulse control disorder, characterised by failure to resist a harmful urge or impulse 
PD Parkinson's disease 
PPN Pendunculopontine nucleus 
PQI Parkinson's Queensland Incorporated 
R Recipients 
STN Subthalamic nucleus 
VIM Ventralis intermedius nucleus of thalamus 
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SUMMARY 
 
This study was aimed at providing additional insight into the outcomes from DBS for Parkinson’s 
disease, how these vary between people who have had the procedure, and over time.  
New perspectives have been gained on the outcomes from DBS for Parkinson’s disease by sampling 
the experiences of both recipients of DBS and carers. Data were collected mostly by structured 
interview from 52 cases involving 91 participants – 46 recipients and 45 carers. Post-DBS experience 
ranged from 10-129 (av. 40.1) months at the time of interview.  
There were significant variations in perceived outcomes over time. Some experienced extreme 
variations as a consequence of episodes involving hardware and other problems requiring additional 
surgery. This was reported in 27% of cases. Despite these complications and adverse effects, most 
experiencing these episodic difficulties went on to ultimately report good outcomes. More generally 
there were often noticeable changes in the outcomes from DBS with time – even within the first 12 
months following the procedure, with some symptoms showing sustained improvement and some 
showing reducing benefits with time. 
Holistic assessments of experiences following DBS for PD were largely positive, but in some cases 
there were noticeable differences in the assessments by recipients and carers. For assessments valid 
at the time of interview 26 recipients and 17 carers, together representing 58% of cases, 
commented that the outcome was good. A second group of 11 recipients and 12 carers, together 
representing 31% of cases, reported mixed results but overall a positive experience. A third group of 
6 recipients and 8 carers, together representing 19%1 of cases, reported negatively about the 
outcomes. Following DBS overall quality of life was considered, at the time of interview, to be better 
by28 recipients and 25 carers but worse by 6 recipients and 10 carers. Post-DBS experiences of both 
motor and non-motor symptoms varied greatly between cases. With all symptoms, some 
participants reported that they were worse following DBS, but in the great majority of cases 
symptoms were reported to be the same or better following DBS.  
When considering the average of participant responses, tremor and dyskinesias were considered 
better or much better following DBS, with benefits sustained with time.  
Twelve months after DBS many symptoms were on average considered the same or better after 
DBS, but for many, some decline in benefits was apparent over this period.  
Some symptoms were reported to show no improvement, or be worse following DBS. Twelve 
months after the procedure the average of participant responses indicated that symptoms including 
speech, postural stability, swallowing, handwriting, cognitive function and incontinence were worse.  
There was broad agreement between the assessments of recipients and carers for the outcomes for 
many symptoms, but some differences were noticeable. At some times after DBS, carers reported 
greater improvements than recipients for a range of symptoms including facial expression, difficulty 
walking, slowness or lack of movement, difficulty standing from a chair and freezing. In contrast, 
carers were more likely to give less positive assessments than recipients for symptoms including 
sleep quality, fatigue, cognitive function, mood and behaviour, anxiety, vision, depression and 
quality of life. 
  
                                                             
1 Percentages don’t total 100 because in some cases recipients and their carers gave different responses. 
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INTRODUCTION 
Deep brain stimulation for Parkinson’s disease is now a well-established surgical approach to the 
management of Parkinson’s disease1. It involves placing electrodes at key sites deep in the brain to 
provide continuous electrical stimulation to those sites. DBS can be applied to just one side of the 
brain (unilateral DBS) or both sides (bilateral DBS). The electrical power and signals used for 
stimulation are provided by a device surgically implanted under the skin, usually in the chest area, 
with electrical leads running under the skin to the electrodes in the brain.  
The history of DBS dates back to at least the 1950’s. In its earliest implementation it was used as a 
tool in the surgical treatment of psychiatric illnesses2.  Its potential for the treatment of movement 
disorders, including PD, was demonstrated in 19873. When applied to the subthalamic nuclei (STN) it 
was shown in 1993 to provide significant improvements to symptoms of PD4 and in 1998 reduced 
need for dopamine replacement drugs5.  
Evidence of the benefits and side effects of the procedure are widely documented in the medical 
literature. Extensive reviews of this literature have been conducted by others6,7,8 and further review 
of this medical nature is beyond the scope of this report. However the principal findings of these 
reviews will be summarised to provide background for the study reported in this document. 
Control of motor symptoms of PD is the main treatment goal with DBS9. Over time a number of 
structures in the brain have been investigated as targets for DBS, shown in Table 1. 
Table 1-  Sites for DBS Sometimes Used in the Treatment of PD10 
Site Acronym Comments 
Ventralis intermedius nucleus 
of thalamus 
VIM For tremor, but commonly STN and GPi are now more 
favoured because they can also improve tremor plus 
other PD symptoms. 
Subthalamic nucleus STN Generally now considered the optimal choice for PD, 
depending on PD symptoms. 
Globus pallidus internus GPi Sometimes preferred depending on symptoms, for 
example when treating slowness of movement 
(Bradykinesia) and rigidity. 
Pendunculopontine nucleus PPN Sometimes preferred depending on symptoms, for 
example when treating gait disorders and postural 
instability (axial symptoms). Fasano (2012) reports 
outcomes for this site have been very variable and 
consequently interest in it seems to have waned. 
There are no guidelines for the choice of target for DBS. STN seems to offer the best overall 
management of PD symptoms, but there are special cases when other sites for DBS may be more 
advantageous.  
The outcomes from DBS depend to some degree on the target site chosen. Dopamine replacement 
therapy is a good predictor of outcomes following STN DBS – if a symptom responds to levodopa 
medication there is a good chance that it will respond to STN DBS11. On average STN DBS leads to a 
reduced need for levodopa by about 55% with consequential improvements in dyskinesia.  This 
reduced need for levodopa is not duplicated with GPi DBS12.   
There is good evidence to show that, for many, DBS improves many motor symptoms especially 
when combined with dopamine replacement therapy13,14. In the case of STN DBS for which long term 
data is available, improvements in motor symptoms and dyskinesias are sustained for at least 10 
years, but improvements in slowness of movement (bradykinesia) wear off over time. DBS to STN, 
GPi and VIM targets can all relieve tremor. Gait and balance problems can be resistant to both 
dopamine replacement therapy (DRT) and DBS. DRT and STN DBS have about the same effect on 
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postural instability and gait problems but both applied together can give short term improvements 
above the single treatment regime. Despite STN DBS, gait and balance problems get worse over 
time. Speech can be adversely affected by DBS. Speech worsens after STN DBS – 56% have 
worsening speech one year after implantation, rising to 90% at 8 years. At one year after 
implantation, loudness is increased but intelligibility decreased15. 
Non-motor symptoms of PD also respond to DBS16. In addition to the worsening speech already 
mentioned above there is a slight but significant decline in episodic memory, executive function and 
abstract reasoning, but this decline is similar to that observed in patients on drug therapy alone. 
Bilateral GPi DBS has fewer cognitive or behavioural adverse effects than STN DBS , at least over a 10 
year period. Pre-existing impulse control disorders (ICDs) are markedly improved with STN DBS, but 
some studies have reported ICDs after DBS. Through its ability to reduce the need for DRT, STN DBS 
can improve dopamine dysregulation syndrome (DDS), a syndrome characterised by self-control 
problems such as gambling, hypersexuality or addiction to medication.  
Apathy, mood disorders and anxiety can all be affected by DBS17.  Apathy worsens with STN DBS. At 
about 5 months after surgery 54% suffer apathy which is reversible in half of recipients at 1 year. 
Mood disorders (depression or mania) can occur after STN DBS in either transient or persistent form.  
Following STN DBS depression can get better, stay the same or get worse. Suicidal tendencies have 
been reported following STN DBS – 0.9% of patients attempting and half of these being successful. 
Suicide rates are highest in the first year after the surgery. Manic symptoms occur in about 4% of 
those given STN DBS, sometimes in the immediate post-operative period. Manic symptoms can last 
for hours or a few days and seem to be linked to the DBS stimulation and sometimes respond to 
different stimulation settings.  At 7 months after surgery there are no overt mood variations. Other 
DBS targets occasionally affect mood, but to a lesser extent that STN – some in fact leading to 
improvements. Various effects on anxiety have been reported for STN DBS – some reporting better, 
the same or worse anxiety following DBS.  
Bilateral STN DBS improves continuous sleep time, sleep efficiency and decreases nocturnal 
dystonia. These improvements relate to improvement in bradykinesia, increase in bladder capacity 
and reduced daytime sleepiness because of reduced DRT. There is some evidence that STN DBS leads 
to improvement in restless leg syndrome, but other studies indicate that it is made worse by the 
reduction in DRT following STN DBS. PPN DBS can significantly increase REM sleep, but there is little 
evidence that other DBS sites influence sleep in this way. 
Like any medical procedure, DBS can lead to complications and unwanted side effects (adverse 
effects). The incidence of these outcomes varies significantly between centres performing the DBS 
procedure18,19.  In the case of STN-DBS, published results are summarised in Table 2. 
Few reviews have been published that have included subjective assessments by patients or carers on 
their perceptions of outcomes. A clinical review of patients complaining of “failed” DBS procedures20 
revealed a wide range of circumstances influencing their opinions. These included errors in original 
diagnosis, misplaced leads and hardware complications and DBS programming inadequacies. With 
appropriate intervention about half these patients ultimately had good outcomes. In another study21 
the expectations and subjective perceived outcomes of 30 patients were assessed before and 3 
months after surgery. In terms of perceived subjective outcomes, 8 (26.7%) were negative, 8 (26.7%) 
were mixed and 14 (46.7%) were positive. Those reporting negative outcomes were characterised by 
unrealistic expectations and higher apathy and depression scores, before and after surgery, 
compared with those reporting more positive outcomes. In another study differences in perceptions 
about quality of life aspects were reported for DBS recipients and carers22. While quality of life was 
significantly improved by DBS, at 12 months following the procedure carers ratings of quality of life 
were lower than those given by recipients. 
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Table 2– Some Complications and Adverse Effects after STN-DBS23,24 
Complication Incidence 
(range reported from different DBS 
performing centres) 
Haemorrhage 0.2 – 12.5% 
Transient post-operative confusion 1 – 36% 
Infection <1 – 15.2% 
Electrode breakage 0 – 15.2% 
Electrode migration or misplacement 0 – 18.8% 
All hardware related complications 
(skin erosions, wire breakages, battery 
or electronic malfunction) 
2.7 – 50% 
The present study was designed to provide further information about outcomes from DBS for 
Parkinson’s disease from the point of view of both those who have had the procedure and their 
carers. Throughout this work the word “carer” is used loosely to describe anyone who has a close 
personal knowledge of the condition of the person with PD before and after DBS surgery. It might be 
a spouse, partner, adult child or friend.  The study goal was to provide additional information about 
the range of perceived outcomes and how these vary over time to help patients and their loved ones 
form more realistic expectations of the procedure, and through that, contributing to less stressful 
and better outcomes. 
The results of this study should be interpreted with caution. Parkinson’s disease is progressive and 
DBS is not a cure. This study was limited to people who have had DBS for PD. Comparison with 
others who were being treated non-surgically was beyond the scope of this work but has been 
reported by others25,26. Also a number of DBS recipients participating in this study had other health 
problems which may, in ways difficult to quantify, have influenced their perception of the progress 
of Parkinson’s disease. 
METHODS 
Participants 
Participants were drawn from the DBS support network of Parkinson’s Queensland. An important 
decision made in scoping this survey was that there would be no exclusions – all outcomes were 
valid outcomes. In a few cases this meant that responses could only be obtained from carers 
because of physical or mental impairment of recipients. 
Participants (either recipients of DBS, carers or both) for about 50 cases were sought to provide a 
significant sample of perceived outcomes. As it transpired, progressive analysis of the responses 
obtained suggested that established patterns of outcomes were not changing significantly at about 
this number (saturation).  
Those invited to participate were chosen in date order of the DBS procedure, (known for those 
having the procedure 2011 onwards), otherwise in alphabetical order based on surname. Invitations 
included a written copy of the structured questionnaire that was the survey instrument used in this 
study thus allowing invited participants to make an informed decision as to whether or not they 
wished to be included.  Of those approached to be involved in the study six recipients and their 
carers declined to participate and a further 25 did not respond to the invitation. 
This study was directed towards cases involving post-DBS experience - of about 12 months or longer. 
Agreement to participate was based on pre-view of the survey instrument. The study was guided by 
the values and principles of ethical conduct for human research specified by Australian authorities27. 
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Procedure 
The survey was based on structured interviews, where possible with both DBS recipients and their 
carers. The questions for the interviews were workshopped by members of the DBS support group of 
PQI. They reflect those issues seen as important by members of that group, recognising that post-
DBS experiences for many vary over time. Details of the survey instrument are shown in Appendix 1. 
There were essentially 4 parts to the survey instrument: (1) a preamble describing the background, 
purpose, scope and confidentiality undertakings, (2) questions relating to personal background of 
the DBS recipient and procedure history, (3) PD symptoms following DBS – Part A, important 
changes noticed by both DBS recipient and the carer, in their own words, and (4) PD symptoms 
following DBS – Part B, a subjective scaling of changes in PD symptoms by both DBS recipient and 
carer. Responses for (3) and (4) were sought over several time intervals covering the first 12 months 
following DBS, nominally 1, 6 and 12 months after the procedure and also at the date of interview.  
The special focus on the first 12 months after DBS was determined by frequent anecdotes from our 
members about significant changes over this “settling in” period during which time there are often 
significant adjustments to the DBS settings as part of standard clinical practice.  
Given that participants were widely scattered geographically, nearly all interviews were conducted 
by telephone. DBS recipients and their carers were asked whether they would like to be interviewed 
together or separately. Most chose to be interviewed together. Whether interviewed separately or 
together there were frequently differences in responses to some questions.  
Responses were transcribed and recorded on a case basis (i.e. recipient and/or carer responses 
relating to a particular procedure) with personal identities removed. Responses for Part 3 of the 
survey instrument (PD symptoms following DBS – Part A) were analysed using a form of content 
analysis and the graded responses for Part 4 (PD symptoms following DBS – Part B) reported 
graphically to more clearly demonstrate the variations in time.  
RESULTS & DISCUSSION 
Background 
Of the 52 cases studied, the gender balance for those who had the DBS procedure was 27 males and 
25 females with birth years ranged from 1933 to 1968. Interviews were conducted over 2012 and 
2013. At the time of interviews, recipients’ post-DBS experience ranged from 10 to 129 months (Fig. 
1) with the average 40.1 months. 
                             
Fig. 1  Months following DBS procedure for participating recipients 
In all but 2 cases (10 and 11 months) post-DBS experience was 12 months or longer.  In 40 cases 
interviews were possible with both the DBS recipient and the carer, in 6 cases with the recipient only 
and in 5 cases with the carer only so that in all there were 91 participants.  In those cases in which 
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the recipient only was interviewed, a carer wasn’t available or declined to participate. In the cases 
for which a carer only was interviewed, the DBS recipient could not communicate effectively 
because of impairment in writing, speech ability or cognitive function. In one case in which the DBS 
recipient and carer were interviewed, Part B of the structured interview had to be abandoned 
because of the emotional state of the carer and the cognitive impairment of the recipient. 
Most participants did not know the location in the brain that was the target for DBS (Table 1). Except 
for one known case involving PPN DBS, the few who did know identified the subthalamic nucleus 
(STN) as the target in their case. Because of this uncertainty, no analysis of outcomes to DBS could 
be performed on the basis of DBS target. Also, while most participants recalled that there was a 
reduction in PD medication post-DBS, most could not recall with accuracy the details of their 
medication for PD over the time period covered by the survey.  Any further attempt at analysis of 
this aspect was therefore abandoned. 
Fourteen of the 52 cases (27%) reported further surgery related to DBS not including routine and 
expected battery replacement. Some had multiple procedures – this group of 14 reported at least 22 
surgical procedures.  Reasons for these procedures included relocation of leads or probes (5), 
replacement of broken leads (5), replacement of a faulty stimulator (2), hardware eruption through 
skin (1 – multiple sites), relocation of stimulator (2) and infection (4). In those cases involving 
infections, all or some of the implant was replaced. The timing of these post-DBS procedures ranged 
from 1 to 72 months following the initial implantation. These reported complications are consistent 
with published statistics on these events summarised in Table 2.  
Part A – Most Important Changes Noticed by Participants Following DBS 
Procedure 
The spontaneous responses of participants touched on over 100 topics. These were sorted and, 
where closely related, aggregated as indicated in the following tables. Caution must be exercised in 
interpreting some of the responses reported here and in subsequent sections because a number of 
participants had other health problems in addition to Parkinson’s disease (comorbidities).  Some 
could be considered secondary to PD (e.g. fractures caused by falls, and their complications) while 
others were quite separate illnesses (e.g. cancer, arthritis).  In cases where comorbidities existed, 
participants were asked to differentiate as well as they could the separate health impact from PD, 
the focus of this study. 
Participant responses to Part A have been grouped on a category basis and are presented below in 
order of mention frequency at the time of interview, the order thus being in terms of longer term 
effects. For several reasons – different responses from DBS recipient and carer, or the lack of 
contribution on a particular topic by either recipient or carer – the number of cases represented by 
the tabulated data is usually less than the sum of recipient and carer counts.  
1. General Comments on DBS Experience 
Most participants offered holistic reflections of their DBS experience. These are summarised in Table 
3 in which similar comments are clustered. Some who commented that they would or would not 
agree to the procedure again are included in other comment counts (rows) of Table 3. 
Positive comments about the procedure varied in number over the first 12 months after the 
operation (Table 3), with more frequent mentions in the early months. Comments reporting a good 
outcome, at least at some time following DBS, were made in 41 of the 52 cases (79%), by either the 
recipient or carer or both.  
The longer term assessments were those reported at the time of interview. At that time a large 
proportion of participants still reported a good outcome, in several cases despite transient 
difficulties in the post-DBS period. Those that mentioned good outcomes at this time included 26 
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DBS recipients, and 17 Carers. Considered on a case basis a good outcome was reported by either 
the recipient or carer or both in 30 cases of the 52 in the study (58%).   
Another group reported mixed outcomes, but on balance considered DBS a positive experience. At 
the time of interview this group included 11 recipients and 12 carers, collectively representing 16 of 
the 52 cases (31%).  
A third group reported negative experiences at various times following DBS.  At least at some period 
following DBS negative experiences were reported in 13 cases (25%) by either the recipient or carer 
or both. However the longer term assessments in this group reported at the time of interview 
comprised 6 recipients and 8 carers representing 10 of the 52 cases (19%). 
Table 3– Numbers of General Comments on DBS Experiences 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Felt a lot better, things going well, 
better quality of life, good 
outcome 
11 4 7 26a 11 10 7 17a 41 30  
Mixed results but on balance 
positive experience 
   11b 1 2  12b 16 16 
Bad experience, didn’t work, 
expectations not met, DBS 
switched off or removed 
2 1 3 6c 1 1 1 8d 13 
 
10 
Would do it again    4e    2f 5 5 
Never do it again, wished it had 
never been done 
   2g    1h 3 3 
At interview post-DBS experience ranged from  a 12-122, b 12-73, c 12-74, d  14-74, e 14-74, f 74-84, g 12-74, h20 
months 
It is important to note that the sum of cases for good, positive and negative responses don’t total to 
52 because some participants views changed over the post-DBS period and some DBS recipients had 
different views to carers. 
2. Comments Related to Motor Symptoms 
Many of the comments made in Part A of the survey related to changes in patient symptoms 
following the procedure. Those comments relating to motor symptoms are grouped here in rank 
order of the number of cases where the comments were made valid for the time of interview.  
Posture and Balance 
Frequent comments were made about posture and balance. These are shown in Table 4 where 
related terms have been clustered.  A number of DBS recipients and carers reported balance 
problems, falls or both with increasing frequency over the first 12 months following the procedure. 
At some time post-DBS these problems were reported by the recipient, carer or both in 20 of the 52 
cases (38%). Reports relating to the longer term presence of these problems were those relevant at 
the time of interview (up to 112 months for recipients and up to 66 months for carers). These 
indicated balance and falls were a problem in 12 of the 52 cases (23%) at the time of interview.  
In contrast, some participants reported better balance and fewer falls. Reports of this nature were 
received from the recipient, carer or both at least at some time following DBS in 8 of the 52 cases 
(15%) and at the time of interview in 2 of the 52 cases (4%). 
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Table 4– Number of Comments About Posture and Balance 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Balance problems, having falls 4 7 12 9a 3 6 9 7b 20 12 
Better balance, fewer falls 2 1 1 1c 3 2 2 1d 8 2 
Posture getting worse    1e     1 1 
At interview post-DBS experience ranged from a 5-112, b 14-66, c 27, d 122, e 12 months 
Speech 
Reports relating to speech indicated that for many, speech was perceived to worsen following DBS. 
Speech difficulties were mentioned by the recipient, carer or both at some time post-DBS in 21 of 52 
cases (40%) and valid at the time of interview, in 13 of 52 cases (25%). In contrast, improved speech 
was mentioned in a couple of cases. 
Table 5 – Number of Comments About Speech 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Speech worse 2 2 5 8a 5 6 1 7b 21 13 
Speech better   1 1c   1  2 1 
At interview post-DBS experience ranged from a 12-83, b 24-83, c 60 months 
Gait and Movement 
Reports of movement and gait problems were also common. These were mentioned at some time 
post-DBS in 16 of 52 cases (31%) and at the time of interview, in 6 of 52 cases (12%). In contrast, 
better walking was reported in 13 of 52 cases (25%) at some time during the post-DBS period and in 
one case (2%) at the time of interview. Of note was the relatively high reporting, by both recipient 
and carer, of improved walking about one month after the procedure but this reporting was not 
sustained over the longer periods. 
Other changes in movement or mobility were mentioned in a small number of cases (Table 6). 
Table 6 – Number of Comments About Gait and Other Movement 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Slower movement, freezing, gait 
problems 
2 6 6 1a 1 2 2 5b 16 6 
Walking better 6 1 1  6 2 2 1c 13 1 
Handwriting worse  2 1 1d 1    3 1 
Freezing improved, eliminated    1d     1 1 
Unable to walk     1e     1 1 
Handwriting better     1    1 0 
Spasms in legs   1      1 0 
At interview post-DBS experience ranged from a 37, b11-83, c 12, d 14, e 74, months 
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Tremor 
Improvements in tremor were reported, particularly in the period immediately following the 
procedure (Table 7). At some time in the post-DBS period improvements in tremor were reported in 
16 of 52 cases (31%) and at the time of interview in 6 of the 52 cases (12%).  
In some cases tremor was reported to have returned. This was mentioned at some time in the post-
DBS period in 5 of 52 cases (10%) and at the time of interview in 3 of 52 cases (6%). 
Table 7 -  Number of Comments About Tremor 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Tremor improved 12 4  6a 4 2 2 1b 16 6 
Tremor back  2  2c 1   1d 5 3 
At interview post-DBS experience ranged from  a 14-97, b 31, c 11-27, d 66 months 
Stiffness, Rigidity and Dystonia 
There were a small number of reports relating to stiffness, rigidity or dystonia (Table 8). Reduced 
stiffness or rigidity was reported at some time in the post-DBS period in 6 of 52 cases (12%) and at 
the time of interview in 1 case (2%).  Reports of improvements in dystonia at some time in the post-
DBS period came from 3 in 52 cases (6%). Other features in this grouping were mentioned 
infrequently, Table 8. 
Table 8- Number of Comments About Stiffness, Rigidity and Dystonia 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
No or reduced rigidity, stiffness  3  1a 2    6 1 
Stiff neck    1b     1 1 
Dystonia improved 1    2    3 0 
Stiffness worse 1  1      2 0 
Slowness of movement   1      1 0 
Arm paralysis 1        1 0 
Dystonia worse       1  1 0 
At interview post-DBS experience ranged from  a 97, b 17 months 
Other Motor Symptoms 
Reports of changes in other motor symptoms were relatively small in number, Table 9. In the 
immediate period following DBS, carers reported a loss of the characteristic masked (Parkinson’s) 
face in 7 of 52 cases (13%). In some cases this masked face returned, at the time of interview in 2 of 
52 cases (4%). 
Table 9- Number of Comments About Other Motor Symptoms 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS procedure 1 6 12 Int 1 6 12 Int   
Comments           
“Parkinson’s face” returned    1a   1 1b 2 2 
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Difficulty swallowing, drooling    2c   1  2 2 
Manipulation skills worse 1  1 2b   1 1b 2 2 
Involuntary eyelid closure 
(blepharospasm) 
  1 1d 1 1   3 1 
Restless legs   1 1e     1 1 
No more restless legs    1f     1 1 
“Parkinson’s face” gone     6 2   7 0 
Weak legs 1  1      1 0 
Manipulation skills better  1       1 0 
At interview post-DBS experience ranged from a 17, b 12, c 27-37, d 34, e 23, f 84 months 
 
3. Comments Related to Non-Motor Symptoms 
Non-motor symptoms also generated a significant number of comments. These follow, once again in 
order of the number of reports describing views at the time of interview. 
Memory and Judgment 
Reports of the kind “impaired judgement, impaired cognitive function or memory loss” were more 
common from carers, Table 10. In all, reports of this nature were received from the recipient, carer 
or both in 15 of 52 cases (29%) at some time post-DBS and for 9 of 52 cases (17%) at the time of 
interview. The higher count over the entire post-DBS period, in contrast to comments valid at the 
time of interview is consistent with some of the reports of this nature being generated by episodic 
events occurring in the first 12 months following DBS. These included short term disorientation, poor 
judgement while driving, examples of transient poor financial decision making and atypical or 
irrational shopping. 
Table 10- Number of Comments About Memory, Judgement and Intellectual Function 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Impaired judgement, cognitive 
function, memory loss 
1 2 2 3a 3 3 2 6b 15 9 
Concentration improved   1      1 0 
At interview post-DBS experience ranged from  a 14-129, b 13-61 months 
Other comments valid at interview that have been grouped under this heading include vagueness, 
confusion, loss of memory (especially with words), loss of verbal skills, loss of numeracy skills, 
thinking patterns “scrambled”,  poor financial decisions and dementia. 
In contrast, one recipient reported improved concentration at about 12 months following the 
procedure. 
Sleep 
There were a number of references to changes in sleep quality (Table 11). Over the first 12 months 
following the procedure there was increasing mention of poorer sleeping experiences. Poorer sleep 
was mentioned at some time in the post-DBS period in 12 of 52 cases (23%) and at the time of 
interview in 6 of 52 cases (12%).  
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Table 11- Number of Comments About Sleep 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Sleeping worse 1 1 4 4a 1 2 4 4b 12 6 
Sleeping better 4 3  2c 5    8 2 
Sleeping more        1d 1 1 
Having nightmares  1 1 1e   1 1e 1 1 
Having vivid dreams 1  1      2 0 
Better at turning in bed 1    1    2 0 
At interview post-DBS experience ranged from a 11-129, b 14-219, c 46-60, d 14, e 12 months 
Over the first 12 months following the procedure there was increasing mention of poorer sleeping 
experiences. Poorer sleep was mentioned at some time in the post-DBS period in 12 of 52 cases 
(23%) and at the time of interview in 6 of 52 cases (12%).  
In contrast there were a number of reports of better sleeping for the first month or so following the 
procedure. Similar reports of this nature came from the recipient and observed by the carer. Reports 
of this nature related to at least some period following DBS in 8 of 52 cases (15%) and valid at the 
time of interview in 2 of 52 cases (4%).  
Dreams or nightmares were mentioned in a few cases. Being able to turn more easily in bed was also 
mentioned in two cases. 
Mood and Behaviour 
There were many features mentioned that have been grouped as mood and behaviour (Table 12). 
The most common report in this grouping, largely from carers, was for a more relaxed and happier 
DBS recipient. There were 9 in 52 cases (17%) in which this was mentioned at some time in the post-
DBS period, and 4 in 52 cases (8%) when this was mentioned valid at the time of interview. 
Tiredness or fatigue was also reported in a number of cases – in 7 of 52 cases (13%) at least at some 
time post DBS and in 4 of 52 cases (8%) valid at the time of interview. 
Table 12– Number of Comments About Mood and Behaviour 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
More relaxed, happier, brighter 2   1a 5 3 2 3b 9 4 
Tired, fatigued 1 3 3 2c  1 1 2d 7 4 
Obsessive, compulsive, 
impulsive, uninhibited behaviour 
    3 3  2c 6 2 
Apathy, lethargy worse 1 1 1  1 3 2 2e 4 2 
Stays around home        2f 2 2 
More confident 2 1 1 1g 1  2  4 1 
More caring nature     1   1h 2 1 
Emotional   1 1i     1 1 
Less depressed     1 1 1 1j 1 1 
More anxious        1k 1 1 
Hallucinations   1 1l     1 1 
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Euphoria, elation 5 1   3 1   7 0 
Mood swings  1   2 1 1  3 0 
Aggressive, intolerant   1  1  1  2 0 
Less caring nature     1 1   2 0 
Less anxious     2    2 0 
Hilarity  1       1 0 
Depressed  1    1 1  1 0 
Apathy, lethargy better  1       1 0 
Introverted  1       1 0 
More stable mood   1      1 0 
More independent     1    1 0 
Hyperactive 1 1       1 0 
At interview post-DBS experience ranged from a 60, b 12-23, c 12-13, d 15-61, e 37-60,  f 12-84, g 97, h 22, 
i 27,  j 12, k 129, l 27 months 
Behaviour that could be described as obsessive, compulsive, impulsive or uncharacteristically 
uninhibited was reported by a number of carers, but by no recipients. Behaviour of this nature was 
reported in 6 or 52 cases (12%) at some time post-DBS and in 2 of 52 cases (4%) at the time of 
interview. 
Apathy or lethargy was mentioned by both recipients and carers in a number of cases – noticed in 4 
of 52 (8%) at some time following DBS and in 2 of 52 (4%) valid at the time of interview. Another 
perhaps related series of comments implied decreasing wish for socialisation (was happy to just stay 
around the home). Comments of this nature were reported just by carers in 2 of 52 cases (4%) valid 
at the time of interview. 
There were many more comments grouped under the mood and behaviour heading (Table 12) but 
reported in relatively few cases. One that requires further comment is the cluster “Euphoria, 
elation”. The reports of this nature were noteworthy in two respects – they were observations from 
both recipients and carers and all were restricted to the first few months following the procedure. In 
that short period this topic was reported in a total of 7 of 52 cases (13%), but none valid at the time 
of interview. 
Pain 
Pain was reported by a number of participants. This topic was often difficult to assess for the 
purposes of this survey. The important questions were whether the perceived pain was either a 
feature of Parkinson’s disease or DBS, because many participants had other health problems in 
addition to PD (comorbidities). The responses in Table 13 reflect their assessment of relevancy to 
this survey. 
Table 13 - Number of Comments About Pain 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Headaches 1   1a     2 1 
Pain over scalp 1 1  1b     2 1 
Back pain    1c      1 1 
Leg or hip pain  2    1   3 0 
Chest pain 1  1      2 0 
Neck pain 1 2 2   1   2 0 
At interview post-DBS experience ranged from a 17, b 11, c 27 months 
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Most reports of pain were understandably from the recipient, but in two cases carers reported 
observing the effects. Various sites were mentioned for the pain but headaches, pain over the scalp 
and back pain were valid at the time of interview, each for 1 in 52 cases (2%). Pain at other sites was 
reported in a small number of cases, but not active at the time of interview. 
Other Non-Motor Symptoms 
Comments relating to other non-motor symptoms of Parkinson’s disease were relatively few in 
number (Table 14). Improved eating or weight gain was mentioned in 4 of 52 cases (8%) at some 
time in the post DBS period, but such comments became fewer with time following DBS with only 1 
case (2%) mentioned at the time of interview. In some cases, where weight maintenance had been a 
problem before DBS, this change was welcomed. Worse incontinence was mentioned in 2 of 52 
cases (4%) at some time following the procedure, but only in one case observed by the carer at the 
time of interview, 61 months following the procedure. Improved ability to smell and taste was 
reported for the months following the procedure in 2 of 52 cases (4%), but none at the time of 
interview. 
Table 14– Other Comments Related to Non-motor Symptoms 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Weight gain, eating better  2 2  1 1 1 1a 4 1 
Incontinence worse  1      1b 2 1 
Smell and taste improved 1 1 1   1   2 0 
Nauseous 1        1 0 
Feeling unwell   1      1 0 
Sight improved 1 1 1      1 0 
At interview post-DBS experience ranged from a 129, b 61 months 
4. PD Management After DBS 
There were a number of reports that were related to PD management following DBS (Table 15).  
Both recipients and carers reported a desire for more information to be provided to them about DBS 
prior to the procedure. Reports of this nature were received in 7 of 52 cases (13%).  
Another group, predominantly carers, reported a desire for more information and support following 
DBS. This applied in 5 of 52 cases (10%). 
At the time of interview there were reports of the benefits of DBS wearing off in 5 of 52 cases (10%). 
Those recipients reporting this had DBS at some time in the range 24-129 months prior to interview.  
Table 15-  Number of Comments About PD Management After DBS 
 DBS recipient Carer Cases 
total 
Cases 
at Int 
Months after initial DBS 
procedure 
1 6 12 Int 1 6 12 Int   
Comments           
Would like more information 
prior to DBS 
   4a    5b 7 7 
Would like more information and 
support following DBS 
   2c    5d 5 5 
Benefits of DBS wearing off    4e  1  2f 5 5 
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Involuntary movements, 
dyskinesia worse 
 1 1 1g  1 1 1h 2 2 
Difficulty in finding correct DBS 
settings/ frequent adjustments 
    1  1 1i 2 1 
No stable management of PD 
symptoms 
 1 2 1i  1   2 1 
High levels of PD medication 
needed 
   1j     1 1 
Totally dependent        1k 1 1 
Sensations in brain or body 
caused by DBS or settings change 
9 5 1      9 0 
Better “on” time 2        2 0 
Decrease in medication 1 1       1 0 
At interview post-DBS experience ranged from a 13-22, b 13-85, c 22-74, d 15-74, e 24-129, f 60-66, g 14, h 12, I 13,  
j 73, k 74 months 
 Other comments relating to the management of PD post-DBS were wide ranging but any particular 
topic was only mentioned in a relatively small number of cases at interview (Table 15). One that had 
more numerous mentions early in the post-DBS period related to sensations experienced caused by 
DBS or adjustment of DBS settings. A number of recipients reported sensations when the settings 
were changed. Examples included sensations like a current surge or jolt in the brain, tingling in the 
brain or elsewhere in the body or transient “fogginess” in the brain, but these sensations were 
transient - all such comments were restricted to the first few months following the procedure. None 
was mentioned at the time of interview. 
Part B – Perceived Changes in Symptoms Compared With Conditions Prior 
To DBS 
In this section participants were asked to rate experiences of 32 symptoms according to the scale 
shown in Table 16.  
Participants were asked to provide numeric scores according to the table shown above for the times 
following the DBS procedure of 1 month, 6 months, 12 months and at the time of interview. In those 
few cases where participants had had repeat DBS procedures, timing was measured from the first 
implantation. Where interviews were conducted close to the first anniversary of the procedure, the 
same responses were recorded under the headings “after 12 months” and “at interview”.   
Not all participants provided scores for every question. In the following figures, NR = number of 
recipients that provided a score of 0-5, and NC = number of carers who provided a score of 0-5. 
Results are shown in two columns. The left column shows the scores provided by the combined pool 
of DBS recipients and carers and are therefore based on the total number (NR+ NC) of responses. The 
right column shows the difference in scores between DBS recipients and carers intended to identify 
symptoms that were assessed differently by DBS recipients and carers. 
Table 16– Scoring Schedule 
Score Meaning 
5 Much better after DBS 
4 Better after DBS 
3 About the same as before DBS 
2 Worse after DBS 
1 Significantly worse after DBS 
0 Not applicable (e.g. did not exhibit this symptom up to this point in time) 
Blank Unwilling or unable to answer 
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Care is needed in interpreting data relating to differences in response – for a number of cases 
different numbers of recipients and carers responded, and there were a number of unmatched 
recipients and carers. Nevertheless the numbers presented do give some indication of any 
differences in assessment by recipients as a group and by carers as a group. Number (R-C) is, for 
each score, the number of recipients minus the number of carers giving this score. If positive, this 
indicates more recipients than carers gave that response. If negative, more carers than recipients 
gave that response.   
1. Motor Symptoms 
People living with PD can experience a wide range of symptoms, but not all known symptoms. 
Scores of “0” indicated that the symptom in question was not relevant (applicable) to the case 
reported on by that participant. For motor symptoms considered here these “not applicable” 
responses are shown in the table below. The figures shown apply to the initial assessment of 
participants, i.e. in the period immediately following DBS (1 month). In some cases the symptom did 
become “applicable” at some time after DBS, in which circumstances the “not applicable” responses 
decreased over time as can be seen in some of the following Figures. Comments following in this 
section refer to those who did experience the symptoms i.e. did return responses in the range 1-5.  
Results for the different symptoms are presented in bar chart form in the order of decreasing 
applicability as indicated in the Table 17. The most common symptom on this list is handwriting. All 
participants who responded to this question (90 in total) indicated this was applicable to their 
situation (i.e. none described it as “not applicable”). In contrast freezing wasn’t relevant for 45 of the 
88 participants who responded to this symptom. 
Table 17– Relevance (Applicability) of Motor Symptoms to Individual Cases 
Symptom Results Reported initially as “Not Applicable” 
Figure number Participant count Percentage 
Handwriting 2 0/90 0 
Difficulty walking 3 4/88 5 
Speech 4 7/89 8 
Postural stability 5 11/90 12 
Slowness or lack of movement 6 13/88 15 
Facial expression 7 15/79 19 
Difficulty standing from a chair 8 19/90 21 
Difficulty turning in bed 9 15/60 25 
Tremor 10 24/91 26 
Stiffness and rigidity 11 24/88 27 
Swallowing 12 38/88 43 
Freezing 13 45/88 51 
Results in Table 17 show that there is wide variation in the relevance (applicability) of many motor 
symptoms. The subsequent discussion of results in this section for these motor symptoms is 
restricted to those responses that indicated that the symptom in question was applicable i.e. for 
which a score was given in the range 1-5.   
All scores in the range 1-5 were averaged at each of the post-DBS time intervals chosen for this 
study. The results are listed in Table 18 in the same order as Table 17 (i.e. based on the relevance of 
symptoms in order most relevant to least relevant). These averages give an indication of the average 
outcomes perceived by the participants. A more graphic indication of the differences in scores, and 
variation over time is provided in the following Figures (2-13), also shown in the same order as Table 
17. 
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Table 18– Average Scores (1 – 5) for Motor Symptoms Listed in Decreasing Order of 
Applicability  
Symptom DBS  
+ 1 month 
DBS  
+ 6 months 
DBS  
+ 12 months 
At interview 
 R C R C R C R C 
Handwriting 3.29 3.13 3.04 2.96 2.84 2.86 2.56 2.60 
Difficulty walking 3.70 3.77 3.58 3.52 3.26 3.29 2.95 2.86 
Speech 3.28 3.10 3.12 3.00 2.72 2.49 2.49 2.34 
Postural stability 3.38 3.54 2.90 2.95 2.68 2.92 2.65 2.71 
Slowness or lack of movement 3.81 3.92 3.72 3.62 3.68 3.62 3.35 3.15 
Facial expression 3.80 3.94 3.68 3.71 3.55 3.64 3.35 3.43 
Difficulty standing from a chair 3.54 3.67 3.34 3.41 3.21 3.23 2.86 2.87 
Difficulty turning in bed 3.78 3.86 3.65 3.67 3.48 3.62 3.43 3.50 
Tremor 4.49 4.31 4.43 4.28 4.42 4.20 4.26 4.18 
Stiffness and rigidity 3.87 3.91 3.71 3.67 3.66 3.52 3.31 3.18 
Swallowing 3.12 2.75 3.08 2.76 3.00 2.70 2.79 2.40 
Freezing 3.85 3.91 3.37 3.59 3.00 3.32 2.72 2.75 
Participants reported a general improvement to many motor symptoms following DBS, but there 
were significant differences depending on the symptom.  
Significant and sustained improvements 
Of all symptoms surveyed tremor (Table 18 and Fig. 10) showed the strongest positive improvement 
following DBS. Most participants indicated that this was much better after DBS and that the 
improvements were sustained over time with average scores of 4.42/4.20 (R/C) 12 months after DBS 
and 4.26/4.18 (R/C) at the time of interview.  
Sustained improvements 
Other symptoms that on average showed improvement included slowness or lack of movement (Fig. 
6), facial expression (“Parkinson’s face”) (Fig. 7), difficulty turning in bed (Fig. 9) and stiffness and 
rigidity (Fig. 11). Symptoms in this group were reported by many participants to be better or much 
better following DBS with average scores above 3 through to the time of interview.  
Improvements but not sustained 
Another group of symptoms, including difficulty walking (Fig. 3), difficulty standing from a chair (Fig. 
8) and freezing (Fig. 13), showed initial improvement, but more decline in improvement with time 
such that at the time of interview the average scores were less than 3. 
Scores for speech and postural stability showed that on average these symptoms showed some 
improvement in the few months following the procedure but that this improvement wasn’t 
sustained. 
In the case of speech (Fig. 4) the largest number of responses in the first 12 months following DBS 
was for a score of 3 (much the same after DBS) but scores of either 1 or 2 (worse after DBS) 
increased with time following the procedure such that at 12 months the average scores were 
2.72/2.49 (R/C) and at interview, the largest number of responses was for a score of 2 with overall 
averages of 2.49/2.34 (R/C). These results were in broad agreement with those in Part A in which 
there was frequent mention of poorer speech (Table 5). 
 As discussed earlier in relation to Part A of the survey, balance problems and falls were common 
experiences. In Part B postural stability was assessed by participants in terms of propensity for 
falling. Improvements in postural stability (Fig. 5) were reported by some in the first month or so 
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following DBS, but often this was not sustained. By the end of the first year following DBS, the score 
with the largest number of responses was 2 and the average scores 2.68/2.92 (R/C) indicating that at 
this time this symptom was worse than before DBS for many. The number reporting a score of 2 
increased monotonically with time following DBS such that at the time of interview the average 
scores had reduced to 2.65/2.71 (R/C). 
Little or no improvements 
Some symptoms appear to show little or no improvement with DBS. These include handwriting (Fig. 
2) and swallowing (Fig. 12). Most participants for whom these symptoms were relevant gave a score 
of 3 (much the same after DBS) for these symptoms with some evidence of worsening by the time of 
the interview. The average responses 12 months after DBS were 2.84/2.86 (R/C) for handwriting and 
3.00/2.70 (R/C) for swallowing, and even lower at the time of interview. 
Comparison of responses, recipients and carers 
Allowing for the fact that, for many symptoms, there were different numbers of recipients and 
carers providing scores, recipients and carers were generally consistent in the scores given. However 
there were some notable differences with some symptoms. With tremor (Fig. 10) there were some 
differences reported in the level of improvement – more carers than recipients gave a score of 4 but 
more recipients than carers gave a score of 5. Early in the post-DBS period more carers than 
recipients reported scores of 5 (much better after DBS) for the symptoms of difficulty walking (Fig. 
3), slowness or lack of movement (Fig. 6), difficulty standing from a chair (Fig. 8) and freezing (Fig. 
13) but this difference was not sustained at later times. More carers than recipients gave scores of 
either 4 or 5 for facial expression (Fig. 7).  
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Motor Symptom Responses in Order of Decreasing Applicability 
 
 
 
   
Fig. 2 Handwriting   (NR = 45, NC = 45) 
   
Fig. 3 Difficulty Walking (NR = 43, NC = 45) 
   
Fig. 4 Speech (NR = 44, NC = 45) 
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Motor Symptom Responses in Order of Decreasing Applicability (cont.) 
 
 
 
   
Fig. 5 Postural Stability (NR = 45, NC = 45) 
   
Fig. 6 Slowness or Lack of Movement (NR = 44, NC = 44)  
   
Fig. 7 Facial Expression (NR = 38, NC = 41) 
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Motor Symptom Responses in Order of Decreasing Applicability (cont.) 
 
 
 
   
Fig. 8 Difficulty Standing From Chair (NR = 45, NC = 45) 
   
Fig. 9 Difficulty Turning in Bed (NR = 31, NC = 29) 
   
Fig. 10 Tremor (NR = 47, NC = 44)  
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Motor Symptom Responses in Order of Decreasing Applicability (cont.) 
 
 
 
   
Fig. 11 Stiffness and Rigidity (NR = 44, NC = 44) 
   
Fig. 12 Swallowing (NR = 45, NC = 43) 
   
Fig. 13 Freezing (NR = 44, NC = 44) 
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2. Non-Motor Symptoms 
For non-motor symptoms considered in this section, the numbers of “not applicable” responses 
are shown in the table below. As for the motor symptoms discussed in the previous section, the 
figures shown in the table apply to the assessment of participants in the period immediately 
following DBS (1 month). In many cases the symptom did become “applicable” at some time 
after DBS, in which cases the “not applicable” responses decreased over time as can be seen in 
some of the following Figures. Comments following in this section refer to those who did 
experience the symptoms i.e. did return responses in the range 1-5. Results for the different 
symptoms are presented in bar chart form in the order of decreasing applicability as indicated in 
Table 19 shown below. 
Table 19– Relevance (Applicability) of Non-Motor Symptoms to Individual Cases 
Symptom 
Results Reported initially as “Not Applicable” 
Figure 
number Participant count Percentage 
Sleep quality 14 3/88 3 
Fatigue 15 9/89 10 
Cognitive function, 
memory and reasoning 
ability 16 17/88 19 
Sense of Smell 17 20/83 24 
Mood and behaviour 18 17/60 28 
Constipation 19 22/74 30 
Anxiety 20 31/85 36 
Severity of on/off periods 21 35/82 43 
Dystonia 22 43/84 51 
Apathy 23 46/89 52 
Vision 24 44/83 53 
Depression 25 47/87 54 
Dyskinesias 26 45/84 54 
Pain 27 42/77 55 
Incontinence 28 46/81 57 
Restless leg 29 49/86 57 
Thermoregulatory 
dysfunction 30 49/60 82 
Hallucinations or delusions 31 72/85 85 
It can be seen from Table 19 that there is wide variation in the relevance (applicability) of many 
symptoms. Dystonia, apathy, vision problems, depression, dyskinesias, pain, incontinence, restless 
leg, thermoregulatory dysfunction, hallucinations or delusions were reported as “not applicable” by 
more than 50% of participants. Thermoregulatory dysfunction (excessive sweating) and 
hallucinations or delusions were reported as “not applicable” in over 80% of cases. The subsequent 
discussion of results in this section for these non-motor systems is restricted to those responses that 
indicated that the symptom in question was applicable i.e. for which a score was given in the range 
1-5.   
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As for the motor symptoms, all scores in the range 1-5 for the non-motor symptoms were averaged 
at each of the time intervals chosen for this study. The results are listed in Table 20 and give an 
indication of the average outcomes perceived by both recipients and carers. Symptoms are listed in 
the same order as for Table 19. A more graphic indication of the variation of scores over time is 
provided in the following Figures (14-31), also shown in the order indicated in Table 19. 
Table 20– Average Scores (1 – 5) for Non-Motor Symptoms Listed in Decreasing Order of 
Applicability 
Symptom DBS  
+ 1 month 
DBS  
+ 6 months 
DBS  
+ 12 months 
At interview 
 R C R C R C R C 
Sleep quality 3.56 3.43 3.58 3.57 3.59 3.53 3.47 3.55 
Fatigue 3.44 3.37 3.28 3.20 3.21 3.05 2.88 2.83 
Cognitive function, memory and 
reasoning ability 
3.14 2.80 3.03 2.80 2.97 2.73 2.72 2.49 
Sense of Smell 3.14 2.96 3.16 3.04 3.11 3.08 3.05 3.12 
Mood and behaviour 3.71 3.05 3.52 3.05 3.14 3.05 3.43 3.32 
Constipation 3.19 3.10 3.26 3.19 3.07 3.16 2.94 3.05 
Anxiety 3.59 3.52 3.48 3.33 3.43 3.07 3.10 3.00 
Severity of on/off periods 4.00 4.08 3.91 3.87 3.90 3.57 3.73 3.52 
Dystonia 4.20 4.14 4.05 4.14 3.75 3.62 3.15 3.14 
Apathy 3.10 3.23 3.05 3.18 3.15 3.10 3.14 3.04 
Vision 3.25 2.95 3.20 2.95 3.28 2.82 2.95 2.50 
Depression 3.71 3.42 3.43 3.05 3.23 3.00 3.23 3.00 
Dyskinesias 4.33 4.48 4.22 4.38 4.12 4.35 3.79 4.09 
Pain 3.39 3.65 3.26 3.50 3.33 3.50 3.29 3.37 
Incontinence 2.89 2.88 2.83 2.88 2.76 2.81 2.55 2.50 
Restless leg 3.63 3.61 3.63 3.61 3.56 3.53 3.10 3.16 
Thermoregulatory dysfunction* 3.33 3.00 3.17 3.00 3.17 3.20 3.33 3.40 
Hallucinations or delusions* 2.75 3.20 2.88 3.40 3.38 3.40 3.30 3.80 
* Notes: The numbers of participants returning scores 1-5 for (a) thermoregulatory dysfunction and (b) hallucinations or 
delusions were small – (a) 11 and (b) 13 so the averages shown for these must be treated with added caution. 
Significant improvements 
The most significant improvements commonly reported by some were for dyskinesia (Fig. 26), 
dystonia (Fig. 22) and in improvements in the severity of on/off periods (Fig. 21).  Improvements in 
dyskinesia were fairly constant over time, with average scores of 4.12/4.35 (R/C) 12 months after 
DBS and 3.79/4.09 (R/C) at the time of interview. However the improvements with dystonia and 
severity of on/off periods showed some decline over time. Both had average scores over 4 at one 
month following DBS, but by the 12 month mark had dropped to 3.75/3.62 (R/C) in the case of 
dystonia and 3.90/3.57 (R/C) in the case of severity of on/off periods. At the time of interview there 
had been further declines in the average scores, more so for dystonia, but average scores were still 
higher than 3 at that time. 
Sustained improvements  
Scores for symptoms sleep quality, mood and behaviour and pain showed that, on average, 
sustained improvements were perceived, at least by recipients.  The non-motor symptom of highest 
applicability was sleep quality (Fig. 14). Most reported the same or better sleep quality following 
DBS, with improvements sustained for many. Average scores were 3.59/3.53 (R/C) 12 months 
following the procedure and 3.47/3.55 (R/C) at the time of interview. A similar outcome was 
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reported for mood and behaviour (Fig. 18) [3.14/3.05 (R/C) at 12 months and 3.42/3.32 (R/C) at 
interview]. Two features of the results for mood and behaviour are especially noteworthy –(a) the 
generally lower scores given by carers and (b) the improvement in scores from both recipient and 
carer at the time of interview compared with those at 12 months following DBS.  Another symptom 
that was reported to show sustained improvement was pain (Fig. 27) [3.33/3.50 (R/C) at 12 months 
and 3.29/3.37 (R/C) at interview].  
Improvements but not sustained 
Fatigue (Fig. 15), anxiety (Fig. 20), depression (Fig. 25) and restless leg (Fig. 28) showed 
improvements after DBS, but these improvements declined such that, at the time of interview, these 
symptoms were reported to be similar to what they were before DBS (average scores ranged 2.83 – 
3.23). In the case of depression it is noticeable that the average scores from carers were consistently 
lower than those from recipients [3.23/3.00 (R/C) at interview] 
Little or no improvements 
Sense of smell (Fig. 17), constipation (Fig. 19), apathy (Fig. 23), and vision (Fig. 24) did not appear to 
be much affected by DBS. The most common score was 3 and this did not vary much over time. The 
results for apathy did not reflect the frequency or worsening of this symptom following DBS 
reported in the literature (see Fasano [25]). The reasons for this are unclear, but contributing causes 
might include a lack of understanding of the nature of the symptom, or some stigma attached to it. 
During the interview process there were a number of responses which were consistent with these as 
possible causes, but further work would be needed to clarify this.  
Few participants responded with scores of 1-5 for Drenching sweats (thermoregulatory dysfunction) 
(Fig. 30) and hallucinations or delusions (Fig. 31), but those that did indicated that these symptoms 
were much the same as before DBS but possibly improving somewhat with time. 
About the same or worse 
Consistent with the results in Part A of the survey, the group of symptoms  cognitive function, 
memory and reasoning ability (Fig. 16) was reported to be about the same or worse after DBS and 
getting worse over time. One month following DBS the average scores were 3.14/2.80 (R/C) and at 
interview 2.72/2.49 (R/C). Of note is the average score from carers being always less than 3.  Similar 
results were also reported for incontinence (Fig. 28) with average scores ranging 2.89 – 2.50 over the 
period just after DBS to the time of interview.  
Comparison of responses, recipients and carers 
There were a number of notable differences between the scoring by DBS recipients and carers for 
the non-motor symptoms, some of which have already been mentioned above. These differences 
can be seen in the average scores shown in Table 20 and also (un-averaged) in column (b) of the 
following Figures. An important qualification to these numbers is that, for many symptoms, there 
were fewer carers (NC) than recipients (NR) providing scores.  
Allowing for this, the data suggest that carers had a more negative assessment for a number of 
symptoms, at least at some time periods following DBS. These symptoms include sleep quality (Fig. 
14b), fatigue (Fig. 15b), cognitive function, memory and reasoning ability (Fig. 16b), mood and 
behaviour (Fig. 18b), anxiety (Fig. 20b), vision (Fig. 24b) and depression (Fig. 25b).  
In contrast, carers tended to have more positive assessments for the symptoms of dyskinesias (Fig. 
26b) and pain (Fig. 27). 
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Non-Motor Symptom Responses in Order of Decreasing Applicability 
 
 
   
Fig. 14 Sleep Quality (NR = 45, NC = 43) 
   
Fig. 15 Fatigue (NR = 45, NC = 44) 
      
Fig. 16 Cognitive function, memory and reasoning ability (NR = 45, NC = 43) 
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Non-Motor Symptom Responses in Order of Decreasing Applicability (cont) 
 
 
   
Fig. 17 Sense of smell (NR = 45, NC = 38) 
   
Fig. 18 Mood and behaviour (NR = 31, NC = 29) 
   
Fig. 19 Constipation  (NR = 44, NC = 30) 
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Non-Motor Symptom Responses in Order of Decreasing Applicability (cont) 
 
 
   
Fig. 20 Anxiety  (NR = 43, NC = 42) 
   
Fig. 21 Severity of on/off periods (NR = 41, NC = 41) 
   
Fig. 22 Dystonia  (NR = 42, NC = 42) 
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Non-Motor Symptom Responses in Order of Decreasing Applicability (cont) 
 
 
   
Fig. 23 Apathy (NR = 45, NC = 43) 
   
Fig. 24 Vision  (NR = 44, NC = 39) 
   
Fig. 25 Depression  (NR = 45, NC = 42)  
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Non-Motor Symptom Responses in Order of Decreasing Applicability (cont) 
 
 
   
Fig. 26 Dyskinesias  (NR = 41, NC = 43) 
   
Fig. 27 Pain (NR = 42, NC = 35) 
   
Fig. 28 Incontinence  (NR = 45, NC = 36) 
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Non-Motor Symptom Responses in Order of Decreasing Applicability (cont) 
 
 
   
Fig. 29 Restless leg (NR = 45, NC = 41) 
   
Fig. 30 Drenching sweats (Thermoregulatory dysfunction) (NR = 31, NC = 29) 
   
Fig. 31 Hallucinations or delusions (NR = 44, NC = 41) 
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3. Quality of life changes 
Two questions were included relating to quality of life – social interaction and overall quality of life. 
Anecdotal accounts prior to this study suggested that some with PD became more introverted and 
isolated as the illness progressed. These questions were included to determine what changes 
occurred to these aspects following DBS. The question about changes in overall quality of life was 
added early in the interview stage of the survey because of its frequent mention in unstructured 
parts of the survey.  As a result formal responses to this question were only available from 74 
participants. 
Table 21 – Relevance (Applicability) of Quality of Life Changes to Individual Cases 
Topic 
Results Reported initially as “Not Applicable” 
Figure 
number Participant count Percentage 
Overall quality of life 32 0/74 0 
Social interaction 33 6/90 7 
 
Table 22– Average Scores (1 – 5) for Quality of Life Listed in Decreasing Order of Applicability 
Topic DBS  
+ 1 month 
DBS  
+ 6 months 
DBS  
+ 12 months 
At interview 
 R C R C R C R C 
Overall quality of life 4.30 4.22 4.30 4.24 4.17 4.00 4.08 3.76 
Social interaction 3.66 3.64 3.74 3.58 3.44 3.24 3.30 3.17 
Overall quality of life scores were among the highest given in this survey. A high proportion gave 
scores of 5 (i.e. much better after DBS). Participants who had experienced a number of difficulties in 
the post-DBS period often still gave high scores to this feature. Details provided in Table 22 and Fig. 
32 show that there is some reduction in scoring over time – an increase in the number of scores of 2 
with time and a monotonic decrease in the number of scores of 5 over time, but many reported high 
scores over all time intervals covered in the survey. However, it should be noted that some 
recipients tended to give higher scores than some carers (Fig. 32b), particularly at the time of 
interview at which time average scores were 4.08/3.76 (R/C). These results are consistent with the 
results of Lewis et al. (2014) (Ref. 22). 
Social interaction (Table 22 and Fig. 33) scores were more mixed. The most common score for the 
first 12 months following DBS was 3 (much the same after DBS), but a significant number also gave 
scores of 4 (better after DBS) or 5 (much better after DBS). But Fig. 33 shows that there was a 
decline in scores over the time periods covered such that, at the time of interview, the most 
common score was 2 (worse after DBS).  For this topic also some recipients tended to give higher 
scores than some carers (Fig. 33b). At interview the average scores were 3.30/3.17 (R/C). 
The results for Overall quality of life and Social interaction were in broad agreement with the holistic 
assessments of DBS in Part A (Table 3).  
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Life-style Responses in Order of Decreasing Applicability 
 
 
   
Fig. 32 Overall Quality of Life (NR = 37, NC = 37) 
 
   
Fig. 33 Social Interaction (NR = 44, NC = 45) 
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4. Summary of Part B results 
Table 23 below clusters experiences with symptoms on the basis of average scores 12 months 
following DBS and at interview. Details of the variation between participants and with time are 
shown in the Figures in earlier sections of this report and in Tables 18 and 20.  
Table 23– Summary of Perceived Changes to Symptoms Following DBS 
Average 
Perceived  
Outcome  
Motor symptoms 
12 months after 
DBS 
Motor symptoms 
at interview  
(Av. 40.1 months 
after DBS) 
Non-motor 
symptoms 
12 months after 
DBS 
Non-motor 
symptoms 
at interview 
(Av. 40.1 months 
after DBS) 
Better or 
much better 
after DBS  
(score above 
4) 
Tremor  Tremor Dyskinesias  
About the 
same or 
better after 
DBS  
(score range 
3-4) 
Difficulty Walking 
Slowness or lack 
of movement  
Facial expression  
Difficulty standing 
from a chair 
Difficulty turning 
in bed  
Stiffness and 
rigidity 
Freezing  
Slowness or lack 
of movement  
Facial expression  
Difficulty turning 
in bed  
Stiffness and 
rigidity 
 
Sleep quality 
Fatigue 
Sense of Smell  
Mood and 
behaviour 
Constipation 
Anxiety 
Severity of on/off 
periods 
Dystonia 
Apathy 
Vision 
Depression 
Pain 
Restless leg 
Thermoregulatory 
dysfunction 
Hallucinations or 
delusions  
Dyskinesias 
Sleep quality 
Sense of Smell  
Mood and 
behaviour 
Anxiety 
Severity of on/off 
periods 
Dystonia 
Apathy 
Depression 
Pain 
Restless leg 
Thermoregulatory 
dysfunction 
Hallucinations or 
delusions 
Worse after 
DBS  
(score less 
than 3) 
Handwriting 
Speech  
Postural stability 
Swallowing 
Handwriting 
Difficulty walking 
Speech 
Postural stability 
Difficulty standing 
from a chair 
Swallowing 
Freezing 
Cognitive 
function, memory 
and reasoning 
ability  
Incontinence 
Fatigue 
Cognitive 
function, memory 
and reasoning 
ability 
Constipation 
Vision 
Incontinence 
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CONCLUSIONS 
This study has provided a new perspective on the outcomes from DBS for Parkinson’s disease by 
sampling the experiences of both recipients of DBS and also the carers. Information was collected for 
52 cases involving 91 participants (46 recipients and 45 carers). The results provide new information 
about the frequency of different symptoms in Parkinson’s disease and the perceived impact of these 
symptoms following the DBS procedure, and how these impacts change with time.  
DBS is an exacting surgical treatment for PD. In 27% of the cases covered in this survey, further DBS 
related surgery was necessary to achieve or restore optimal benefits from the procedure. In a 
number of cases the circumstances leading to further surgery represented a very stressful episode 
for the DBS recipient and the carer, but most were ultimately pleased with the outcomes following 
this additional intervention. 
There was a high degree of consistency between Part A and Part B of the survey. The open- ended 
section of the survey (Part A) revealed many features of importance to DBS recipients and carers, 
ranging from changes in PD management, changes in symptoms and impact on their lifestyle. Their 
comments were in broad agreement with the scaling of symptom changes in Part B of the survey. 
On average, the outcomes from DBS for PD revealed in this survey were in broad agreement with 
previously published results showing improvements across a wide range of symptoms. However in 
this study the outcomes varied significantly between different DBS recipients and over time.  
Significant improvements in quality of life, reduced or eliminated tremor and dyskinesia were 
reported by many. These improvements were often sustained over long periods.  
A wide range of motor and non-motor symptoms were reported to be at least the same or better 
after DBS, but in some cases there was considerable variability in experiences between participants 
and over time. The improvements in some symptoms following DBS were sustained, but others 
declined with time, some noticeably even within 12 months of the procedure. 
Some symptoms appeared worse on average after DBS – these included postural stability, speech 
and cognitive function. 
While there was often broad agreement between the assessments of outcomes from DBS recipients 
on the one hand, and carers on the other, there were noticeable differences for some symptoms and 
outcomes at different times following DBS. When this happened, the carer tended to give a less 
positive assessment of the improvement following DBS. Examples included sleep quality, fatigue, 
cognitive function, memory and reasoning ability, mood and behaviour, anxiety, vision, depression 
and quality of life. 
 
 
*** 
Page | 42   
 
APPENDIX 1 – SURVEY INSTRUMENT 
Preamble 
People contemplating Deep Brain Stimulation (DBS) for Parkinson’s disease often ask us questions 
like “what can I expect to experience after the procedure?”. We are conducting a survey of those 
who have had experience with DBS to help us provide more widely based answers to such enquiries. 
The results of our survey will be written into a report which, together with other information, will be 
made available to those interested in the range of outcomes reported by the participants in this 
survey. 
What follows DBS not only affects those who have had the procedure but also those that care for 
them, family members and friends. The treating neurologist is the primary reference point for 
information, but access to the neurologist is restricted to periodic visits and not always available to 
carers, family and friends. Importantly, those who have had the procedure are in a unique position 
to provide a holistic commentary on their journey with PD following DBS, particularly how they have 
changed over time and how in turn those changes have affected family, friends and carers.  
PD is a highly individualistic disease – every person with PD has their own story. This is true with or 
without DBS. An important contribution to the preparation for life after DBS is an understanding of 
the mosaic of previous experiences of those who have gone before – as many as possible to provide 
a realistic appreciation of the commonly experienced phases of recovery, changes in the 
management of PD and the impact on loved ones. 
As someone who has had DBS we are approaching you to see if you are willing to help us with this 
important task by sharing with us your experiences. Any information provided will be treated in 
confidence. Any written accounts of the survey will have personal information removed to preserve 
the anonymity of participants unless they have previously provided written consent for them to be 
identified. There is no compulsion about any aspect of this survey – potential participants are free to 
decline to participate or to withdraw at any time without the need to give any reason. 
Participants sought for this survey include those who have had DBS for PD, and also where possible 
their carers and family so as to gain the holistic response that we seek. In the first instance we are 
sending you this letter so that you can see the questions we wish to ask. A short time later we will 
phone you to determine your willingness to participate, and if you are, to take you through the 
questions of the survey. We would like to repeat the process with the carer so that both viewpoints 
are captured.  
I sincerely hope that you can help us in this way.  
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Personal background 
  DBS for PD 
1 Name (optional)  
2 Age  
3 Gender  
4 Date diagnosed PD  
5 Previous illness to PD  
6 Date DBS implanted  
7 DBS site?  
8 Other illnesses in addition to PD  
9 PD medication before DBS  
 
Procedure History 
1. Have there been further periods in hospital related to DBS requiring surgery after the initial implant 
procedure? (e.g. battery replacement, correction of adverse effects etc). If so please provide dates 
and details. 
2. Have there been further periods in hospital related to DBS but not requiring further surgery after the 
initial implant procedure? (e.g. physiotherapy, speech therapy etc). If so please provide dates and 
details. 
PD symptoms following DBS 
We would like to ask you two series of questions – Part A, your description of the changes you noticed and 
Part B, a quantitatively scaled comparison of changes to symptoms after DBS. (There may be some overlap 
between parts A and B) 
PD symptoms change over time, with or without DBS. In this section we are asking you to rate your perception 
of symptom severity compared with your recollections of what they were before DBS.  
Part A 
Briefly describe the most important changes you noticed over the period indicated in the table. 
Period Most important changes (PwP) 
DBS + 1 month Medication? 
Frequency of DBS setting changes and your experiences following the change? 
Other? 
DBS + 6 months Medication? 
Frequency of DBS setting changes and your experiences following the change? 
Other? 
DBS + 12 months Medication? 
Frequency of DBS setting changes and your experiences following the change? 
Other? 
DBS to now Medication? 
Frequency of DBS setting changes and your experiences following the change? 
Other? 
 
Period Most important changes (Carer) 
DBS + 1 month  
DBS + 6 months  
DBS + 12 months  
DBS to now  
 
General Comments on DBS Experience (PwP and Carer) 
 
Date of interview: 
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Part B 
In this section we would like you to compare your perception of your symptoms before and after DBS at different times 
relevant to your situation. Where appropriate use the scale:  
5 = much better after DBS 
4 = better after DBS  
3 = much the same after DBS 
2 = worse after DBS 
1 = significantly worse after DBS 
0 = not applicable 
 
 
  
  PwP Carer 
    Time since DBS (months ) Time since DBS (months) 
 Common Symptoms 1  6  12 Now 1  6  12 Now 
1 Tremor?         
2 Stiffness / rigidity?         
3 Slowness or lack of movement?         
4 Postural instability – unsteadiness, falls?         
5 Difficulty walking?         
6 Difficulty standing from a chair?         
7 Freezing?         
8 Speech?         
9 Handwriting?         
10 Swallowing?         
11 Constipation?         
12 Incontinence?         
13 Sleep quality (disruption/dreams etc)?         
14 Turning over in bed?         
15 Restless leg?         
16 Pain?         
17 Fatigue?         
18 Apathy?         
19 Anxiety?         
20 Depression?         
21 Hallucinations or delusions?         
22 Sense of smell?         
23 Vision?         
24 Cognitive function, memory and reasoning ability?         
25 Facial expression?         
26 Dyskinesias?         
27 Severity of on/off periods?         
28 Dystonia? (sustained muscle contractions)         
29 Changes in mood and behaviour?         
30 Drenching sweats (thermoregulatory dysfunction)?         
31 Social interaction?         
32 Overall quality of life?         
33 Any other symptom, not listed above, that is important 
to your case (please specify)? 
        
Page | 45   
 
REFERENCES 
 
1 Marks WJ Jr (Ed): Deep Brain Stimulation Management Cambridge UP 2011 
2 Hariz MI, Blomstedt P & Zrinzo L: Deep Brain Stimulation Between 1947 and 1987:the Untold Story Neurosurg 
Focus Vol 29, No.2 (2010) 
3 Benabid AL, Pollak P, Louveau A, Henry S & de Rougemont J: Combined (thalamotomy and stimulation) 
stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson’s disease. Appl Neurophysiol Vol. 50, 
344-346 (1987)  
4 Benabid AL, Pollak P, Gross et al.: Acute and long term effects of subthalamic nucleus stimulation in 
Parkinson’s disease. Stereotact Func Neurosurg Vol.62, 76-84 (1994) 
5 Limousin P, Krack P, Pollak P,Benazzouz A, Ardouin C, Hoffmann D et al.: Electrical stimulation of the 
subthalamic nucleus in advanced Parkinson’s disease N Engl J Med Vol.339, 1105-1111 (1998)  
6 Volkmann J & Deuschl G: Deep Brain Stimulation Ch 43, Handbook of Clinical Neurology, Vol 84 (3rd series) 
261-277 Elsevier 2007 
7 Benabid AL, Chabardes S, Mitrofanis J & Pollak P: Deep brain stimulation of the subthalamic nucleus for the 
treatment of Parkinson’s disease Lancet Neurol., Vol 8, 67-81 (2009) 
8 Fasano A, Daniele A & Albanese A: Treatment of motor and non-motor features of Parkinson’s disease with 
deep brain stimulation Lancet Neurol. Vol 11, 429-42 (2012) 
9 Fasano – Treatment of PD with DBS (2012) p.429 
10 Adapted from Marks – DBS Management (2011), p.2 and Fasano – Treatment of PD with DBS (2012) p.429, 
p.436 
11 Bronstein JM et al. Deep Brain Stimulation for Parkinson’s Disease: An Expert Consensus and Review of Key 
Issues Arch Neurol. Vol 68 (2) 165-171 (2011) p.166 
12 Fasano – Treatment of PD with DBS (2012) p.430 
13 Benabid – DBS of STN for PD (2009) p.71 
14 Fasano – Treatment of PD with DBS (2012) p.430, 431 
15 Fasano – Treatment of PD with DBS (2012) p.432 
16 Fasano – Treatment of PD with DBS (2012) p.432, 433 
17 Fasano – Treatment of PD with DBS (2012) p.434 
18 Benabid – DBS of STN for PD (2009) p.72 
19 Boviatsis EJ, Stavrinou LC, Themistocleous M, Kouyialis AT and Sakas DE. Surgical and hardware 
complications of deep brain stimulation. A seven-year experience and review of the literature Acta Neurochir 
Vol 152, 2053-2062 (2010) 
20 Okun MS, Tagliati M, Pourfar M, Fernandez H, Rodriguez RL, Alterman RL and Foote KD Management of 
Referred Deep Brain Stimulation Failures Arch Neurol. Vol 62 1250-1255 (2005) 
21 Maier F et al. Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to 
clinical measures in Parkinson’s disease: a mixed-method approach J Neurol Neurosurg Psychiatry Vol 84, 
1273–1281 (2013) originally published on linet: May 28 2013 doi:10.1136/jnnp-2012-303670 
22 Lewis CJ, Maier F, Eggers C, Pelzer EA, Maarouf M, Moro E, Zurowski M, Kuhn J, Woopen C and Timmermann 
L Parkinson’s disease patients with subthalamic stimulation and carers judge quality of life differently 
Parkinsonism & Related Disorders Vol 20, 514-519 (2014) 
23 Benabid – DBS of STN for PD (2009) p.74-75 
24 Boviatsis – Complications of DBS (2010) p.2059 
25 Weaver FM, Follett K, Hur K, et al. Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients with 
Advanced Parkinson’s Disease: A Randomized Controlled Trial J Amer Med Association Vol 301, 63-73 (2009) 
26 Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, 
Wheatley K, Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced 
Parkinson’s disease (PD SURG trial): a randomised, open label trial Lancet Neurology Vol 9, 581-591 (2010) 
27 Anon National Statement on Ethical Conduct in Human Research Australian Government (2007) 
http://www.nhmrc.gov.au/guidelines/publications/e72 accessed 26 Sept 2013 
